Regulatory Risk & Corporate StrategyFDA Warning Letter Hits Kestra Rival, Raising Scrutiny Risk for ASSURE DefibrillatorSalvado•Jul 17, 2026
Corporate FinanceMedical Device Sector Deploys $1.8B in Strategic Portfolio Shifts as AI Integration AcceleratesSalvado•Mar 29, 2026
Healthcare InvestmentAI Virtual Twins Hit 2,000 Medical Procedures as FDA Guidelines Enable Drug Trial ShortcutsSalvado•Mar 21, 2026